Back to search results

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Abroad (travel likely)Recruiting

Conditions

Bladder Cancer · Recurrent Bladder Cancer · Non-muscle Invasive Bladder Cancer (NMIBC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

    Contact: Study coordinator (Hannah DeCosta) · hannah.decosta@moffitt.org · 813-745-3216
    Contact: Principal Investigator (Scott M Gilbert, MD)

  • University of Iowa, Iowa City, Iowa, United States

    Contact: Study coordinator (Francesca Nugent) · francesca-nugent@uiowa.edu · 319-467-5833
    Contact: Principal Investigator (Kenneth G Nepple, MD)

  • University of North Carolina, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Adrian Gerstel) · Adrian_Gerstel@med.unc.edu · 919-475-6720
    Contact: Principal Investigator (Angela Smith, MD, MS)

  • The Ohio State University, Columbus, Ohio, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Darlene Hancock) · darlene.hancock@vumc.org · 615-322-4063
    Contact: Principal Investigator (Kristen Scarpato, MD)

  • Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

    Contact: Study coordinator (Sung Min Kim) · cistorc@uw.edu · 206-210-4040
    Contact: Principal Investigator (John L Gore, MD, MS)
Study leads

  • John L Gore, MD, MS

    Principal Investigator

    Fred Hutch/University of Washington Cancer Consortium

View source on ClinicalTrials.gov(opens in a new tab)